Clinical Trial Detail

NCT ID NCT01973868
Title Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

Advanced Solid Tumor

Therapies

Cetuximab + Regorafenib

Age Groups: adult senior

No variant requirements are available.